Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

634 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590.
Wakelee HA, Stephenson P, Keller SM, Wagner H, Herskovic A, Komaki R, Marks RS, Perry MC, Livingston RB, Johnson DH; Eastern Cooperative Oncology Group. Wakelee HA, et al. Among authors: komaki r. Lung Cancer. 2005 Jun;48(3):389-97. doi: 10.1016/j.lungcan.2004.11.007. Epub 2005 Jan 5. Lung Cancer. 2005. PMID: 15893008 Clinical Trial.
High-dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas. A preliminary report of a multi-institutional trial (Radiation Therapy Oncology Group Protocol 8801).
Komaki R, Wadler S, Peters T, Byhardt RW, Order S, Gallagher MJ, Herskovic A, Pederson J. Komaki R, et al. Cancer. 1992 Jun 1;69(11):2807-12. doi: 10.1002/1097-0142(19920601)69:11<2807::aid-cncr2820691128>3.0.co;2-o. Cancer. 1992. PMID: 1571912 Clinical Trial.
Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer.
Sause WT, Scott C, Taylor S, Johnson D, Livingston R, Komaki R, Emami B, Curran WJ, Byhardt RW, Turrisi AT, et al. Sause WT, et al. Among authors: komaki r. J Natl Cancer Inst. 1995 Feb 1;87(3):198-205. doi: 10.1093/jnci/87.3.198. J Natl Cancer Inst. 1995. PMID: 7707407 Clinical Trial.
Dose intensity in lung cancer treatment.
Cox J, Ball D, Belani C, Choi N, Gralla R, Halle J, Komaki R, Le Chevalier T, Ohnoshi T, Quoix E, et al. Cox J, et al. Among authors: komaki r. Lung Cancer. 1994 Mar;10 Suppl 1:S11-3. doi: 10.1016/0169-5002(94)91661-6. Lung Cancer. 1994. PMID: 8087500 No abstract available.
Combined modality therapy in small cell lung cancer.
Bunn P, Arriagada R, Choi N, Feld R, Gregor A, Jett J, Johnson B, Komaki R, Kristjansen P, Murray N, et al. Bunn P, et al. Among authors: komaki r. Lung Cancer. 1994 Mar;10 Suppl 1:S25-8. doi: 10.1016/0169-5002(94)91664-0. Lung Cancer. 1994. PMID: 8087517 Review. No abstract available.
634 results